综述

热敷治疗睑板腺功能障碍的研究进展

Research progress of warm compresses in the treatment of meibomian gland dysfunction

:935-941
 
睑板腺功能障碍(meibomian gland dysfunction,MGD)是眼科常见疾病,是蒸发过强型干眼的主要原因。基于人群流行病学的调查显示:MGD亚洲的发病率为46.2%~69.3%。目前,MGD治疗的方式包括眼睑清洁、热敷、睑板腺按摩、人工泪液、抗生素等,其中热敷为常用的家庭治疗方法。由于不同的热敷方式、温度、时间、频次及依从性,导致应用热敷治疗MGD到目前为止还没有统一标准。另外,热敷的不良反应如视物模糊、皮肤烫伤等,也没有引起临床足够重视。因此,为提高热敷的临床疗效及减少其不良反应,未来进行热敷的规范化指导或治疗很有必要。
Meibomian gland dysfunction (MGD) is a common ophthalmic disease, which is the main cause of evaporative dry eye. Population-based studies have suggested that the prevalence of MGD is high in Asia, with a reported incidence of 46.2% to 69.3%. Current modalities of MGD treatment include lid hygiene, warm compresses,massage, artificial lubricants, systemic and topical antibiotics, etc., among which warm compress is a common at-home treatment. Due to different eyelid warming methods, temperature, durations of heat application, frequency and compliance, there is no uniform standard for the application of warm compress to the treatment of MGD.In addition, adverse events of warm compress, such as blurred vision and thermal damage, have not attracted enough attention in clinical practice. Therefore, in order to improve the clinical efficacy of warm compress and reduce its adverse events, it is necessary to conduct standardized guidance or treatment of warm compress in the future. Based on the above considerations, this article will briefly review the application of warm compress to the treatment of MGD.
其他期刊
  • 眼科学报

    主管:中华人民共和国教育部
    主办:中山大学
    承办:中山大学中山眼科中心
    主编:林浩添
    主管:中华人民共和国教育部
    主办:中山大学
    浏览
  • Eye Science

    主管:中华人民共和国教育部
    主办:中山大学
    承办:中山大学中山眼科中心
    主编:林浩添
    主管:中华人民共和国教育部
    主办:中山大学
    浏览
推荐阅读
出版者信息